Firstly we show that ATG7-mediated and/or pharmacological autophagy inhibition in CML cells leads to a decrease in glycolysis and an increased flow of labeled carbons through the TCA cycle. Here, ATG7 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.